Mildronate, a Novel Fatty Acid Oxidation Inhibitor and Antianginal Agent, Reduces Myocardial Infarct Size Without Affecting Hemodynamics

Explore this paper's citation graph

Summary

It is demonstrated for the first time that a 10-day treatment with mildronate reduced myocardial IS in an experimental model of acuteMyocardial ischemia, without any effect on hemodynamics.

Type
article
Published
2006-03-01
Cited by
55
References
39

Keywords

Medicine, Ventricle, Hemodynamics, Ischemia, Myocardial infarction

References

Cited by

Related papers